In the News

AAM Comments on End of Year Funding Bill
December 18, 2024
white house
AAM & Biosimilars Council Statement on Presidential Election
November 7, 2024
Capitol at sunet, biosimilar legislation
Biosimilars Council Urges House to Pass Critical Patent Thicket Legislation
September 20, 2024
2024 AAM generic & Biosimilar Savings Report
Biosimilar Medicines Saved $12.4 Billion in 2023
September 5, 2024
Professional in a laboratory using a microscope.
Biosimilars Council Submits Comments, Applauds FDA Draft Guidance Regarding Interchangeability
August 21, 2024
Monoclonal antibodies (Adalimumab)
PBM Schemes to Control Biosimilar Humira Are Denying Patients Savings – New Analysis Shows PBM Strategies and Brand 'Product Hopping' Are Suppressing Uptake of Lower Cost Biosimilar Adalimumab
July 22, 2024

Filter by Keyword

Filter by Audience

Filter by Category

Filter by Keyword

Filter by Issue

Filter by Category

MENU